PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-233.51%
Both yoy net incomes decline, with CRK at -52.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
370.00%
Some yoy growth while CRK is negative at -55.32%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
46.67%
SBC growth well above CRK's 3.30%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-161.00%
Both reduce yoy usage, with CRK at -8.59%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-161.00%
Both reduce yoy usage, with CRK at -113.05%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-10.81%
Both negative yoy, with CRK at -43.89%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-50.59%
Both yoy CFO lines are negative, with CRK at -1.75%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-11.86%
Both yoy lines negative, with CRK at -46.26%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
41.18%
Acquisition growth of 41.18% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
11.86%
Purchases growth of 11.86% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
16.07%
Liquidation growth of 16.07% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-10.17%
We reduce yoy other investing while CRK is 7509.04%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-6.51%
Both yoy lines negative, with CRK at -46.27%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.